Bioleaders Corporation (KOSDAQ:A142760) announced private placement of 1,930,505 11th registered convertible preferred shares at a price of KRW 5,180 per share for gross proceeds of KRW 10,000,015,900 on February 9, 2021. The transaction will include participation from funds managed by new investor Asset One Asset Management. The preferred shares bear cumulative participating dividend of 1% per annum. Each preferred share is convertible into a common share between February 18, 2022 and February 17, 2026. Each preferred share is subject to hold period of 1 year and will be issued at premium to par value of KRW 500 per share. The expected payment date is February 18, 2021. The transaction has been approved by the board of directors of the company.